Gastric parietal cell and thyroid autoantibodies in patients with burning mouth syndrome.

CONCLUSION: Approximately 37.5% of 884 BMS patients have serum GPCA/TGA/TMA positivity. Moreover, 12.3%, 21.6%, and 22.7% of 884 BMS patients have the serum GPCA, TGA, and TMA positivities, respectively. Only 5.1% and 7.1% of TGA/TMA-positive BMS patients have hyperthyroidism and hypothyroidism, respectively. It needs further studies to know whether GPCA-positive BMS patients may finally become as having autoimmune atrophic gastritis. PMID: 32883568 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32883568?dopt=Abstract

Source: J Formos Med Assoc - August 30, 2020 Category: General Medicine Authors: Chiang CP, Wu YC, Wu YH, Chang JY, Wang YP, Sun A Tags: J Formos Med Assoc Source Type: research